8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
	May 6, 2019 Date of Report (Date of earliest event reported)
	HESKA CORPORATION (Exact name of Registrant as specified in its charter)
Delaware		000-22427	77-0192527
(State or other jurisdiction of incorporation)		(Commission File Number)	(I.R.S. Employer Identification No.)
	3760 Rocky Mountain Avenue Loveland, Colorado 80538 (Address of principal executive offices, including zip code)
(970) 493-7272 (Registrant’s telephone number, including area code)
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class		Trading Symbol	Name of Exchange On Which Registered
Public Common Stock, $.01 par value		HSKA	The Nasdaq Stock Market LLC

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 6, 2019, Heska Corporation (the “Company”) announced the formal appointment of Ms. Catherine I. Grassman to serve as the Company’s Executive Vice President, Chief Financial Officer, with continuing responsibility for the Company’s financial management functions including finance and audit, treasury, tax, accounting, capital allocation, strategic financing, information systems, and strategic advisory.

Ms. Grassman, age 43, was appointed as Vice President, Chief Accounting Officer and Controller of the Company in December 2017 and has also been serving as the Company's principal financial officer for Securities and Exchange Commission reporting purposes since that time. She previously served as Corporate Controller from January 2017 to May 2019. Prior to joining the Company, Ms. Grassman held various positions at PricewaterhouseCoopers, LLP, an unaffiliated international public accounting firm, for 15 years, most recently as a Senior Manager. She is licensed in Colorado as a certified public accountant and possesses a Masters of Accountancy and a Bachelors of Business Administration from Stetson University. Ms. Grassman is expected to serve the Company in this new capacity at the pleasure of the Board of Directors for the foreseeable future and until her further promotion or earlier resignation or removal. A copy of the press release announcing Ms. Grassman’s promotion is attached as an exhibit to this current report and incorporated herein by reference.

There are no arrangements or understandings between Ms. Grassman and any other person in connection with her appointment to her new position at the Company, and she does not have any family relationships with any director or executive officer of the Company or any person nominated or chosen to become a director or executive officer of the Company. Finally, there are no “related person” transactions (within the meaning of Item 404(a) of Regulation S-K promulgated by the Securities and Exchange Commission) between Ms. Grassman and the Company, and she did not enter into any new plans, contracts or arrangements with the Company in connection with her promotion.

Item 9.01     Financial Statements and Exhibits.

(d)    Exhibits.

Exhibit No.	Exhibit Description
99.1	Press release of the Company dated May 6, 2019

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	HESKA CORPORATION, a Delaware corporation
Dated: May 6, 2019	By: /s/ Eleanor F. Baker       Eleanor F. Baker       Vice President , General Counsel and Secretary

EX-99.1

Exhibit 99.1

Heska Corporation

Jon Aagaard

Director, Investor Relations

970.619.3033

investorrelations@heska.com

Heska Names Chief Financial Officer to Enhance Executive Team

LOVELAND, CO, May 6, 2019 -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced the promotion of Catherine Grassman from Vice President and Chief Accounting Officer to Executive Vice President, Chief Financial Officer, with continuing responsibility for the Company's financial management functions including finance and audit, treasury, tax, accounting, capital allocation, strategic financing, information systems, and strategic advisory to the Company's Chief Executive Officer. Ms. Grassman will continue to report to Heska's Chief Executive Officer, Mr. Kevin Wilson.

"Catherine has been a cornerstone member of our team for the past couple of years, performing with excellence and distinction, most recently as our Chief Accounting Officer. In addition to her well-earned reputation and proven track record in accounting, audit, and control, Catherine has proven to be an enthusiastic leader, team builder, continual learner, and collaborative senior executive with an inspiring work ethic. Catherine has good judgement and a strong sense of purpose to underpin her extensive financial expertise and strategic mindset. This is a strong combination that inspires important trust for an important role. I couldn't be happier with our selection of Catherine to be our Chief Financial Officer."

Ms. Grassman, age 43, brings nearly 20 years of experience to the position. She was appointed Heska's Vice President and Chief Accounting Officer December 2017, having previously served as the Company's Corporate Controller since January of 2017 as a central figure within the accounting and finance leadership.  Prior to joining Heska, Ms. Grassman spent more than 15 years with PricewaterhouseCoopers, LLP as a senior manager in the audit practice, with later success as Corporate Controller of a private-equity backed company. She is licensed in Colorado as a Certified Public Accountant and possesses a Masters of Accountancy and a Bachelors of Business Administration from Stetson University.

"I'm thrilled to assume this leadership role at a winning, innovative and forward-thinking company like Heska," said Ms. Grassman. "Heska's business model is at the forefront of the industry because the people of Heska are dedicated to and passionate about 'doing well' while 'doing good' by meeting the most important needs of veterinarians, pets, and pet families. I look forward to working with the whole Heska family, our customers, and our investors as we continue on our mission to be the best at what we do."

About Heska

Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 85% of revenue, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment, which represents approximately 15% of revenue. CCA segment includes, primarily for canine and feline use, Point of Care Laboratory testing instruments and consumables under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings

such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.